World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
10999
World Ranking
3634
National Ranking
1678

Joseph B. Domachowske publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joseph B. Domachowske sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 260 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Joseph B. Domachowske D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph B. Domachowske sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Joseph B. Domachowske is affiliated with SUNY Upstate Medical University in the United States and has a research focus within the field of Medicine. Their work spans various subfields including Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health, and Health.

They have contributed extensively to topics such as Respiratory viral infections research, Pneumonia and Respiratory Infections, Viral gastroenteritis research and epidemiology, Vaccine Coverage and Hesitancy, Neonatal Respiratory Health Research, Congenital Diaphragmatic Hernia Studies, and SARS-CoV-2 and COVID-19 Research.

Among frequent collaborators are Cynthia A. Bonville, Amanda Leach, Manika Suryadevara, Tonya Villafana, and Shabir A. Madhi, indicating a network of coauthorship in related research areas.

The scientist's recent publications include:

  • Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity, 2022, New England Journal of Medicine
  • The Future of Respiratory Syncytial Virus Disease Prevention and Treatment, 2021, Infectious Diseases and Therapy
  • Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials, 2023, The Lancet Child & Adolescent Health
  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age, 2021, New England Journal of Medicine
  • Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants, 2020, New England Journal of Medicine

They have published frequently in journals such as the Journal of the Pediatric Infectious Diseases Society, New England Journal of Medicine, Open Forum Infectious Diseases, PEDIATRICS, and Human Vaccines & Immunotherapeutics.

Their publication record shows a focus on respiratory infections and vaccines, with significant work related to respiratory syncytial virus (RSV), including clinical trials and safety evaluations of prophylactic interventions.

Best Publications

  • Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

    M. Pamela Griffin;Yuan Yuan;Therese Takas;Joseph B. Domachowske

  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

    Emmanuel B. Walter;Kawsar R. Talaat;Charu Sabharwal;Alejandra Gurtman

  • Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

    Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh

  • Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment

    Joseph B. Domachowske;Helene F. Rosenberg

  • Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.

    Helene F. Rosenberg;Joseph B. Domachowske

  • Recombinant Human Eosinophil-Derived Neurotoxin/RNase 2 Functions as an Effective Antiviral Agent against Respiratory Syncytial Virus

    Joseph B. Domachowske;Kimberly D. Dyer;Cynthia A. Bonville;Helene F. Rosenberg

  • Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

    Unknown

  • Respiratory Syncytical Virus-induced Chemokine Expression in the Lower Airways Eosinophil Recruitment and Degranulation

    A. Marc Harrison;Cynthia A. Bonville;Helene F. Rosenberg;Joseph B. Domachowske

  • Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity

    Joseph B. Domachowske;Kimberly D. Dyer;Anthony G. Adams;Thomas L. Leto

  • Animal Pneumoviruses: Molecular Genetics and Pathogenesis

    Andrew J. Easton;Joseph B. Domachowske;Helene F. Rosenberg

  • Animal models of human respiratory syncytial virus disease

    Reinout Alexander Bem;Joseph B. Domachowske;Helene F. Rosenberg

  • Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants.

    Joseph B. Domachowske;Anis A. Khan;Mark T. Esser;Kathryn Jensen

  • Schistosoma mansoni infection in eosinophil lineage–ablated mice

    Jonathan M. Swartz;Kimberly D. Dyer;Allen W. Cheever;Thirumalai Ramalingam

  • Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.

    Unknown

  • The Chemokine Macrophage-Inflammatory Protein-1α and Its Receptor CCR1 Control Pulmonary Inflammation and Antiviral Host Defense in Paramyxovirus Infection

    Joseph B. Domachowske;Cynthia A. Bonville;Ji-Liang Gao;Philip M. Murphy

  • Lactobacillus-Mediated Priming of the Respiratory Mucosa Protects against Lethal Pneumovirus Infection

    Stanislaw J. Gabryszewski;Ofir Bachar;Kimberly D. Dyer;Caroline M. Percopo

  • Activated mouse eosinophils protect against lethal respiratory virus infection

    Caroline M. Percopo;Kimberly D. Dyer;Sergei I. Ochkur;Janice L. Luo

  • Respiratory Viruses and Eosinophils: exploring the connections

    Helene F. Rosenberg;Kimberly D. Dyer;Joseph B. Domachowske

  • Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus

    Joseph B. Domachowske;Cynthia A. Bonville;Kimberly D. Dyer;Helene F. Rosenberg

  • Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children.

    Joseph B. Domachowske;Coleen K. Cunningham;Deann L. Cummings;Carl J. Crosley

  • A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3–17 years

    Joseph B. Domachowske;Heidemarie Pankow-Culot;Milagros Bautista;Yang Feng

  • Macrophage inflammatory protein-1α and RANTES are present in nasal secretions during ongoing upper respiratory tract infection

    C. A. Bonville;H. F. Rosenberg;J. B. Domachowske

Frequent Co-Authors

Helene F. Rosenberg
Helene F. Rosenberg National Institute of Allergy and Infectious Diseases
Andrew J. Easton
Andrew J. Easton University of Warwick
Eric A. F. Simões
Eric A. F. Simões University of Colorado Denver
Harry L. Malech
Harry L. Malech National Institutes of Health
Mark T. Esser
Mark T. Esser AstraZeneca (United Kingdom)
John A. Ellis
John A. Ellis Western University of Health Sciences
Gerald M. Rosen
Gerald M. Rosen University of Maryland, Baltimore
Ji-Liang Gao
Ji-Liang Gao National Institute of Allergy and Infectious Diseases
Natasha Halasa
Natasha Halasa Vanderbilt University Medical Center
John P. DeVincenzo
John P. DeVincenzo Middle Tennessee State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in immunology opens doors to various healthcare and research careers. For those interested in clinical roles, nursing offers a practical pathway. Many students transition from different fields through a 12-month accelerated nursing programs online for non nurses, enabling a swift career shift into nursing.

Choosing the right nursing pathway can greatly influence career growth. The easiest absn to get into programs are designed to help students efficiently obtain a Bachelor of Science in Nursing, often providing a smoother admission process and a practical curriculum.

For entry-level positions in nursing, best easiest lpn programs to get into offer accessible routes to Licensed Practical Nurse licensure with less time and financial investment compared to traditional degrees.

Advanced practice roles, such as family nurse practitioners, are critical for specialized patient care and research collaborations. Exploring the easiest fnp program options can help aspiring nurse practitioners find accelerated, flexible programs that suit their career goals.

Best Scientists Citing Joseph B. Domachowske

Trending Scientists

Recently Published Articles